A Clinical Study to Evaluate the Efficacy of a Nutritional Supplement to Improve Carotenoid Content as Measured by a Non-invasive Hyperspectral Absorption Device

A Clinical Study to Evaluate the Efficacy of Nutritional Supplements on Human Health and to Assess the Reliability of Sponsor's Device

The goal of this clinical trial is to evaluate a nutritional supplement in an otherwise healthy adult population. The main questions it aims to answer are:

• Do antioxidant carotenoid levels increase in after supplementation as measured by a non-invasive device?
• Do wellness factors correlate with supplementation?

Researchers will compare the nutritional supplement arm to a placebo group to assess its effects.

Participants will take either the nutritional supplement or placebo once daily for 8 weeks. Participants will be scanned by a non-invasive hyperspectral absorption device to obtain a skin carotenoid score. Participants will also have facial images taken, dermal spectrophotometry measurements of their face, and complete self-assessment questionnaires.

Inclusion Criteria:

• Aged 20-60 years.
• all skin types
• BMI between 18.5-23
• No allergy with carotenoid-containing supplements

Exclusion Criteria:

• subject who have undergone organ excision, organ transplantation, or experienced a skull concussion with extended loss of consciousness in the past 5 years, or with current after effects.
• subjects with diseases such as heart disease, myocardial infarction, cancer, tuberculosis, chronic or acute renal failure, poliomyelitis, arthritis, or asthma
• Subjects undergoing or schedule for long-term treatment, particularly with anti-inflammatory agents, steroids, sedatives, diabetes treatments, medications for blood pressure, hormone therapies, antihistamines, and/or drugs with similar functions,
• subjects who have taken contraceptives or herbal medicines continuously for more than 2 months within the past 3 weeks,
• subjects with any current medical condition, including gynecological disorders, or those undergoing hospital treatment,
• subjects with known allergies to aspirin, antibiotics, fruits, laboratory substances, sunlight or metals;
• Subjects who experience herpes outbreaks more than five times a year or suffer from acute swelling of the skin or mucous membranes;
• Subjects with a history of psychiatric disorders, including sleep disorders or panic disorder